ADVANCEMENTS IN ABLATION CATHETER TECHNOLOGY
DOI:
https://doi.org/10.53555/eijmhs.v4i2.195Keywords:
Ablation Catheter, RF ablation, Cryoablation CathetersAbstract
Cardiac ablation procedures have emerged as a pivotal advancement in the management ofarrhythmias, offering a minimally invasive yet highly effective treatment option for conditions such as atrial fibrillation (AFib). This paper reviews the significant progress in ablation cathetertechnology, highlighting the essential role of catheters in achieving successful outcomes.
Advancements in catheter design, including the introduction of radiofrequency (RF) and cryoablation catheters, have notably improved the precision, safety, and effectiveness of ablation treatments. RF ablation, known for its ability to generate controlled lesions with high success rates, has its limitations, including risks of pulmonary vein stenosis and esophageal injury. The evolution of catheter design has introduced features such as steerable and irrigated tips, as well as integrated sensors, enhancing procedural accuracy and safety. Moreover, advancements in 3D mapping and navigation systems have revolutionized ablation by providingdetailed anatomical and electrical activity maps, thus increasing the precision of targeting arrhythmic sites. The integration of contact force sensing technology and
improvements in catheter design underscores a future where ablation procedures are not only more effective but also safer for patients. This review synthesizes these technological advancements, emphasizingtheir significance in developing cardiac ablation as a preferred treatment modality for arrhythmias and outlining the potential future directions in catheter technology that could further enhance patient care
References
. M. D. O’Neill et al., “Catheter Ablation for Atrial Fibrillation,” Circulation, vol. 116, no. 13, pp.1515–1523, Sep.
, doi: 10.1161/CIRCULATIONAHA.106.655738.
. Y. Gökoğlan et al., “Pulmonary Vein Antrum Isolation in Patients with Paroxysmal Atrial Fibrillation,” Circ
Arrhythm Electrophysiol, vol. 9, no. 5, May 2016, doi: 10.1161/CIRCEP.115.003660.
. J. P. Erinjeri and T. W. I. Clark, “Cryoablation: Mechanism of Action and Devices,” Journal ofVascular and
Interventional Radiology, vol. 21, no. 8, pp. S187–S191, Aug. 2010, doi: 10.1016/j.jvir.2009.12.403.
. H. Calkins et al., “2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheterand surgical
ablation of atrial fibrillation,” Heart Rhythm, vol. 14, no. 10, pp. e275–e444, Oct. 2017, doi:
1016/j.hrthm.2017.05.012.
. K.-H. Kuck et al., “Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation,” NewEngland
Journal of Medicine, vol. 374, no. 23, pp. 2235–2245, Jun. 2016, doi: 10.1056/NEJMoa1602014.
. X. Hu, A. Chen, Y. Luo, C. Zhang, and E. Zhang, “Steerable catheters for minimally invasive surgery:a review and
future directions,” Computer Assisted Surgery, vol. 23, no. 1, pp. 21–41, Jan. 2018, doi:
1080/24699322.2018.1526972.
. A. Müssigbrodt et al., “Irrigated Tip Catheters for Radiofrequency Ablation in VentricularTachycardia,” Biomed Res
Int, vol. 2015, pp. 1–6, 2015, doi: 10.1155/2015/389294.
. A. Rafael and E. Kevin Heist, “Techniques to Optimize Catheter Contact Force during Ablation of Atrial
Fibrillation,” J Innov Card Rhythm Manag, vol. 6, no. 5, 2015, doi: 10.19102/icrm.2015.060506.
. D. Muser et al., “Long-Term Outcome After Catheter Ablation of Ventricular Tachycardia in Patients With
Nonischemic Dilated Cardiomyopathy,” Circ Arrhythm Electrophysiol, vol. 9, no. 10, Oct. 2016, doi:
1161/CIRCEP.116.004328.
. R. Cappato et al., “Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human
Atrial Fibrillation,” Circ Arrhythm Electrophysiol, vol. 3, no. 1, pp. 32–38, Feb. 2010, doi:
1161/CIRCEP.109.859116.
. A. Natale et al., “Paroxysmal AF Catheter Ablation with a Contact Force Sensing Catheter,” J AmColl Cardiol, vol.
, no. 7, pp. 647–656, Aug. 2014, doi: 10.1016/j.jacc.2014.04.072.
. P. Peichl and J. Kautzner, “Advances in Irrigated Tip Catheter Technology for Treatment of CardiacArrhythmias,”
Recent Pat Cardiovasc Drug Discov, vol. 8, no. 1, pp. 10–16, Jun. 2013, doi: 10.2174/1574890111308010003
